Fitch Ratings Anticipating Historic Loan Defaults for April
Since the onset of economic shutdowns across the US, millions of workers have found themselves unemployed and struggling to make ends meet. Although many have applied to employment insurance in addition to the earmarked $1,200 stimulus checks from the government, it is still not enough as the number of mortgages going into forbearance has been […]
Gold Mining Exploration in Idaho is Heating Up
The Deep Dive is currently doing due diligence on Lodge Resources (CSE: LDG), which just a week ago acquired the Lehmi Gold Project in the State of Idaho. In the midst of a deep dive, we thought we might publish for our readership a synopsis of some of the pertinent Idaho mining and drilling info […]
The Totally Practical, Not Even Slightly Sarcastic or Frustrated, Investor’s Guide to SEDAR – Part Three
Congratulations! If you’ve been following along (see Part 1 and Part 2), you’ve now made it to your target company’s document page, which hosts the documents that you can use to conduct your analysis. What could I possibly have left to explain? Well, as it turns out, there are several oddities to a company’s document […]
Supreme Cannabis Files For $9.75 Million ATM Offering
The Supreme Cannabis Company (TSX: FIRE) this afternoon filed paperwork with Sedar indicating that the company will be conducting an at-the-market offering with the BMO Nesbitt Burns for a total figure of $9.75 million. The financing is to take effect April 24, 2020. The paperwork filed indicates that funds will be utilized for general corporate […]
Khiron Life Sciences: An Essential Service of Colombia
Khiron Life Sciences (TSXV: KHRN) is uniquely positioned as a global integrated medical cannabis company. With the recent COVID-19 events, they are currently the only cannabis operator in Colombia with essential service status. Given their cash position, management team, and operational excellence, Khiron is simply in another class than commonly cited peers such as Avicanna, […]
Federal Government Announces $1.7 Billion in Aid For Oil Sector: Funds Will Be Used to Cleanup Canada’s Orphan Wells
The coronavirus pandemic has wreaked havoc across the country, adding a significant blow to already-struggling industries. The oil sector has been hit the hardest, with a barrel of Canadian oil selling for under $5 a barrel even after a deal with OPEC+ to reduce supply was reached. Unlike the US oil industry, where large corporations […]
Trulieve Sees CFO Step Down, Names Replacement Effective June 1
Trulieve Cannabis (CSE: TRUL) has seen chief financial officer Mohan Srinivasan resign from his role with the company with little explanation. Taking his place on an interim basis will be that of the firms controller Ryan Blust, which will be followed by the appointment of Alex D’Amico to the role on a permanent basis effective […]
Internet Of Things Appoints New CEO, Announces New Product Verticals
Internet of Things Inc (TSXV: ITT) this morning announced a shakeup to its management team with the appointment of Michael Lende as the firms CEO and President, in addition to being appointed as a director of the firm. Lende’s top priority will be to re-enact the firms strategic course while capitalizing on the firms unique […]
Food Shortages May Become Reality Amid Coronavirus Pandemic
The global coronavirus pandemic has wreaked havoc across economies, closing down businesses, putting millions out of employment, and racking up trillions in government debt. However, an even more grim implication of the pandemic is a potential global food shortage, which would put millions of people at risk – especially the most vulnerable. Lately, the global […]
Gilead’s Antiviral Drug Fails to Treat Coronavirus, Preliminary Study Shows
Gilead Sciences Inc (NASDAQ: GILD) has been running a randomized clinical trial on the experimental drug remdesivir to determine if it is in fact effective in treating coronavirus patients. The World Health Organization (WHO) accidentally published the results of the preliminary study, which show that the antiviral drug has no benefit in reducing coronavirus symptoms. […]